Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Phathom Pharmaceuticals, Inc. (PHAT) · INSIDER

Data sources

SEC Form 42h ago

House PTR2h ago

SEC 13F2h ago

Robinhood Chain2h ago

Public company

Phathom Pharmaceuticals, Inc.

PHATCIK 0001783183

EDGAR filings Open in network

Price$5.25

1 year-60.5%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence3

PHAT · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Holds over 5% ofevidence
James N. Topper7.4% of class · Schedule 13D · Nov 1, 2026
← Lobbied forevidence
JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026

Planned sales and 5% stakes

Form 144, 13D and 13G

James N. TopperMay seek to influence the company · crossed on Oct 29, 2026 · 6.01M shares7.4% of class13D amendment · filed Nov 2, 2026

Lobbying

$30K reported · de-duplicated

2026 Q2 $15K via firms2026 Q1 $15K via firms

JEFFREY J. KIMBELL & ASSOCIATES, INC.$15K2026 Q2 · posted Aug 26, 2026 · Health issues
JEFFREY J. KIMBELL & ASSOCIATES, INC.$15K2026 Q1 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.